Stock data
Eloxx Pharmaceuticals, Inc. (ELOX)
Eloxx Pharmaceuticals, Inc. (ELOX) reported revenue of US$0.00M and net income of -US$6.00M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$6.44M | -US$6.00M | — |
| 2024 | US$6.36M | — | -US$2.47M | -US$3.14M | — |
| 2023 | US$0.00M | — | -US$17.29M | -US$17.05M | — |
| 2022 | — | — | -US$34.42M | -US$36.06M | — |
| 2021 | — | — | -US$66.02M | -US$66.73M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$4.50M | — |
| 2026-03-31 | — | -US$3.75M | — |
| 2025-06-30 | — | -US$1.89M | — |
| 2025-03-31 | — | -US$1.71M | — |
| 2023-12-31 | — | -US$2.89M | — |
| 2023-09-30 | — | -US$3.59M | — |
| 2023-06-30 | — | -US$4.34M | — |
| 2023-03-31 | — | -US$6.23M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.